Sign inJoin waitlistJoin the waitlist

Nicholas Blondin

Neuro-Oncology Clinical Research Team Leader, Medical Oncology · Yale Cancer Center

Credentials: · · · ·

History

Yale School of Medicine
Present

Yale University
2010–2013
Yale University
2012–2013
Until 2012
Neurology
Yale-New Haven Hospital
2005–2009
Yale School of Medicine
2005–2009
Wesleyan University

Research

Neurologic prognosis in cardiac arrest patients treated with therapeutic hypothermia
Review · The Neurologist · 2011 · First of 2 authors · 62 citations
Clinical and genomic factors associated with seizures in meningiomas
Journal of neurosurgery · 2021 · 33 citations
Diagnosis and management of periodic hypothermia
Neurology Clinical Practice · 2014 · Sole author · 21 citations

DM
Declan McGuone
5 papers
Jennifer Moliterno
4 papers
RF
Robert Fulbright
4 papers
Trisha Gupte
4 papers
Anita Huttner
3 papers
MG
Murat Günel
3 papers
SV
Shaurey Vetsa
3 papers
ZC
Zachary Corbin
3 papers
Arushii Nadar
2 papers
DM
Danielle Miyagishima
2 papers
David Greer
2 papers
Jan Drappatz
2 papers

Clinical trials

Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma
Principal investigator · Active not recruiting · Phase 1
NanoPharmaceuticals LLC
2022–2028
Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease
Site PI · Not yet recruiting · Phase 2
Nuvation Bio Inc.
2027–2032
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Site PI · Recruiting · Phase 1
National Cancer Institute (NCI)
2025–2027
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Site PI · Recruiting · Phase 3
Nuvation Bio Inc.
2023–2030